Suppression of post-hypoxic and post-encephalitic myoclonus with levetiracetam.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 11171914.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Posthypoxic and postencephalitic myoclonus is often poorly controlled with current treatments. The authors successfully treated three patients with posthypoxic and postencephalitic myoclonus by using levetiracetam, a new antiepileptic drug. Levetiracetam appears to be a promising agent for treating action myoclonus caused by hypoxic and encephalitic brain injury-the degree of functional improvement may depend on the severity of associated motor dysfunction.
Medical subject headings
- Hypoxia, Brain
- Myoclonus
- Piracetam